146 related articles for article (PubMed ID: 3109737)
1. Subcutaneous recombinant gamma interferon in cancer patients: toxicity, pharmacokinetics, and immunomodulatory effects.
Thompson JA; Cox WW; Lindgren CG; Collins C; Neraas KA; Bonnem EM; Fefer A
Cancer Immunol Immunother; 1987; 25(1):47-53. PubMed ID: 3109737
[TBL] [Abstract][Full Text] [Related]
2. A phase I study of recombinant interferon gamma administered by s.c. injection three times per week in patients with solid tumours.
Wagstaff J; Smith D; Nelmes P; Loynds P; Crowther D
Cancer Immunol Immunother; 1987; 25(1):54-8. PubMed ID: 3109738
[TBL] [Abstract][Full Text] [Related]
3. A phase I clinical trial of recombinant DNA gamma interferon.
Brown TD; Koeller J; Beougher K; Golando J; Bonnem EM; Spiegel RJ; Von Hoff DD
J Clin Oncol; 1987 May; 5(5):790-8. PubMed ID: 3106584
[TBL] [Abstract][Full Text] [Related]
4. A phase I trial of recombinant human interferon-gamma in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS).
Lane HC; Davey RT; Sherwin SA; Masur H; Rook AH; Manischewitz JF; Quinnan GV; Smith PD; Easter ME; Fauci AS
J Clin Immunol; 1989 Jul; 9(4):351-61. PubMed ID: 2549086
[TBL] [Abstract][Full Text] [Related]
5. Phase I studies of recombinant interferon-gamma.
Laszlo J; Goldstein D; Gockerman J; Hood L; Huang AT; Triozzi P; Sedwick WD; Koren H; Ellinwood EH; Tso CY
J Biol Response Mod; 1990 Apr; 9(2):185-93. PubMed ID: 2160521
[TBL] [Abstract][Full Text] [Related]
6. Immunological effects of treatment with sequential administration of recombinant interferon gamma and alpha in patients with metastatic renal cell carcinoma during a phase I trial.
Ernstoff MS; Gooding W; Nair S; Bahnson RR; Miketic LM; Banner B; Day R; Whiteside T; Titus-Ernstoff L; Kirkwood JM
Cancer Res; 1992 Feb; 52(4):851-6. PubMed ID: 1737346
[TBL] [Abstract][Full Text] [Related]
7. Induced proteins in human peripheral mononuclear cells over a range of clinically tolerable doses of interferon-gamma.
Paulnock DM; Havlin KA; Storer BM; Spear GT; Sielaff KM; Borden EC
J Interferon Res; 1989 Aug; 9(4):457-73. PubMed ID: 2502586
[TBL] [Abstract][Full Text] [Related]
8. Phase I evaluation of combination therapy with interleukin 2 and gamma-interferon.
Weiner LM; Padavic-Shaller K; Kitson J; Watts P; Krigel RL; Litwin S
Cancer Res; 1991 Aug; 51(15):3910-8. PubMed ID: 1906779
[TBL] [Abstract][Full Text] [Related]
9. Immune response induced in small-cell lung cancer by maintenance therapy with interferon gamma.
Pujol JL; Gibney DJ; Su JQ; Maksymiuk AW; Jett JR
J Natl Cancer Inst; 1993 Nov; 85(22):1844-50. PubMed ID: 8230265
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
Utsugi T; Sone S
J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
[TBL] [Abstract][Full Text] [Related]
11. Phase I trial of recombinant interleukin-2 and recombinant beta-interferon in refractory neoplastic diseases.
Paolozzi F; Zamkoff K; Doyle M; Konrad M; Bradley EC; Rudolph A; Newman N; Gullo J; Scalzo A; Poiesz B
J Biol Response Mod; 1989 Apr; 8(2):122-39. PubMed ID: 2786553
[TBL] [Abstract][Full Text] [Related]
12. The determination of an immunologically active dose of interferon-gamma in patients with melanoma.
Maluish AE; Urba WJ; Longo DL; Overton WR; Coggin D; Crisp ER; Williams R; Sherwin SA; Gordon K; Steis RG
J Clin Oncol; 1988 Mar; 6(3):434-45. PubMed ID: 3127550
[TBL] [Abstract][Full Text] [Related]
13. Prolonged interferon-gamma application by subcutaneous infusion in cancer patients: differential response of serum CD14, neopterin, and monocyte HLA class I and II antigens.
Landmann R; Ludwig C; Wesp M; Fisscher A; Obrist R; Knüsli C; Denz H; Obrecht JP
J Interferon Res; 1992 Apr; 12(2):103-11. PubMed ID: 1374454
[TBL] [Abstract][Full Text] [Related]
14. A phase I trial with recombinant interferon gamma (Roussel UCLAF) in advanced cancer patients.
Boue F; Pastran Z; Spielmann M; Le Chevalier T; Subirana R; Sevin D; Paoletti C; Brandely M; Avril MF; Sancho-Garnier H
Cancer Immunol Immunother; 1990; 32(1):67-70. PubMed ID: 2126985
[TBL] [Abstract][Full Text] [Related]
15. [A study of effective administration of recombinant interferon-gamma in renal cell carcinoma regarding immunological influence on peripheral blood lymphocytes].
Kawata N; Ono M; Kodama M; Yamanaka Y; Hirakata H; Hirano D; Fuse T; Takimoto Y
Hinyokika Kiyo; 1995 Jan; 41(1):21-6. PubMed ID: 7900565
[TBL] [Abstract][Full Text] [Related]
16. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory effects of interferon-gamma in patients with metastatic malignant melanoma.
Kopp WC; Smith JW; Ewel CH; Alvord WG; Main C; Guyre PM; Steis RG; Longo DL; Urba WJ
J Immunother Emphasis Tumor Immunol; 1993 Apr; 13(3):181-90. PubMed ID: 8471592
[TBL] [Abstract][Full Text] [Related]
18. Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer.
Robertson MJ; Cameron C; Atkins MB; Gordon MS; Lotze MT; Sherman ML; Ritz J
Clin Cancer Res; 1999 Jan; 5(1):9-16. PubMed ID: 9918197
[TBL] [Abstract][Full Text] [Related]
19. In vivo biological response to recombinant interferon-gamma during a phase I dose-response trial in patients with metastatic melanoma.
Kirkwood JM; Ernstoff MS; Trautman T; Hebert G; Nishida Y; Davis CA; Balzer J; Reich S; Schindler J; Rudnick SA
J Clin Oncol; 1990 Jun; 8(6):1070-82. PubMed ID: 2112184
[TBL] [Abstract][Full Text] [Related]
20. Recombinant interleukin 2 toxicity, pharmacokinetics, and immunomodulatory effects in a phase I trial.
Thompson JA; Lee DJ; Cox WW; Lindgren CG; Collins C; Neraas KA; Dennin RA; Fefer A
Cancer Res; 1987 Aug; 47(15):4202-7. PubMed ID: 3496957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
